Locations:
Search IconSearch

Tag: cardiac myosin inhibition

imaging study of the heart with scales of justice overlay balancing male and female symbols

Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling

End-of-treatment VALOR-HCM analyses reassure on use in women, suggest disease-modifying potential

imaging study of a heart with nonobstructive hypertrophic cardiomyopathy

Myosin Inhibitor for Nonobstructive HCM: No Clinical Benefits but Positive Biomarker and Echo Effects

Phase 3 ODYSSEY-HCM trial of mavacamten leaves lingering questions about potential broader use

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad